Delivery Order SPE2DB22D1103-SPE2DB23FE4ML

Award Date 6/21/23
Potential Completion Date 6/22/23
Potential Value $884
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency awarded a $1,147 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 140mg/ml Repatha SureClick prefilled syringes. The order is being fulfilled under the prime contractor's Corporate Office Division from its facility in Conshohocken, Pennsylvania, with performance spanning July 18-19, 2023. Repatha is an injectable PCSK9 inhibitor medication used to reduce low-density lipoprotein cholesterol levels. This delivery order supports the DLA's...
The Defense Logistics Agency awarded a $884 delivery order to Amerisourcebergen Drug Corporation for 140 mg/ml Repatha SureClick prefilled syringes. The firm fixed price order is being fulfilled from the contractor's facility in Conshohocken, Pennsylvania, with performance spanning July 12-13, 2023. Repatha is an injectable PCSK9 inhibitor medication used to reduce low-density lipoprotein cholesterol levels. This small order for a specialty pharmaceutical supports the DLA's mission to provide...
The Defense Logistics Agency awarded a $1,346 delivery order to Amerisourcebergen Drug Corporation for 140mg/ml Repatha SureClick prefilled syringes. The firm fixed price order is being fulfilled from the contractor's facility in Conshohocken, Pennsylvania, with performance spanning June 22 to June 23, 2023. Repatha is an injectable PCSK9 inhibitor medication used to reduce low-density lipoprotein cholesterol levels. This small order was placed under an existing DLA pharmaceutical supply...
The Defense Logistics Agency awarded a $1,764 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 140mg/ml Repatha SureClick prefilled syringes. The order is being fulfilled under the prime contractor's Corporate Office Division from its facility in Conshohocken, Pennsylvania, with performance spanning August 16-17, 2023. Repatha is an injectable PCSK9 inhibitor medication used to reduce low-density lipoprotein cholesterol levels. This delivery order supports the DLA's...
The Defense Logistics Agency awarded a $1,344 delivery order contract to Amerisourcebergen Drug Corporation for 140mg/ml Repatha SureClick prefilled syringes. The firm fixed price order is being fulfilled from the contractor's facility in Conshohocken, Pennsylvania, with performance spanning July 12-13, 2023. Repatha is an injectable PCSK9 inhibitor medication used to reduce low-density lipoprotein cholesterol levels. This small order was placed under the DLA's Pharmaceutical Prime Vendor...
The Defense Logistics Agency awarded a $2,033.64 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 140 mg/ml Repatha SureClick prefilled syringes. The contract has a period of performance from August 31, 2023 through September 1, 2023, with all work to be conducted by the prime contractor in Conshohocken, Pennsylvania. Repatha is a PCSK9 inhibitor medication used to reduce low-density lipoprotein cholesterol levels and the risk of cardiovascular events. This delivery...
The Defense Logistics Agency awarded a $4,427 delivery order to Amerisourcebergen Drug Corporation for 140mg/ml Repatha SureClick prefilled syringes. The firm fixed price order is being fulfilled from the contractor's facility in Conshohocken, Pennsylvania, with performance spanning July 21-24, 2023. Repatha is an FDA-approved PCSK9 inhibitor medication used to reduce low-density lipoprotein cholesterol. This small order for the cholesterol drug is likely supporting treatment of eligible...
The Defense Logistics Agency awarded a $6,051 delivery order to Amerisourcebergen Drug Corporation for 140mg/ml Repatha SureClick prefilled syringes. The firm fixed price order is being fulfilled from the contractor's facility in Conshohocken, Pennsylvania, with performance spanning September 14 to 15, 2023. Repatha is an FDA-approved PCSK9 inhibitor medication used to reduce low-density lipoprotein cholesterol. This delivery order was issued under an existing DLA pharmaceutical supply vehicle...
The Defense Logistics Agency Troop Support Medical awarded a $884 delivery order to Amerisourcebergen Drug Corp Corporate Office Division for 140 mg/ml Repatha SureClick prefilled syringes. The firm fixed price order is for product delivery to a location in Conshohocken, Pennsylvania between August 2nd and August 3rd, 2023. Repatha is an injectable prescription medication used to reduce the risk of heart attacks, strokes, and coronary revascularization in adults. The Defense Logistics Agency...
The Defense Logistics Agency awarded a $3,537.60 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 140 mg/ml Repatha SureClick prefilled syringes. The contract has a period of performance from July 21, 2023 through July 24, 2023, with all work to be conducted by the prime contractor in Conshohocken, Pennsylvania. Repatha is a PCSK9 inhibitor medication used to reduce low-density lipoprotein cholesterol levels and lower the risk of cardiovascular events. This...
  • SPE2DB22D1103
    Indefinite Delivery Contract
  • SPE2DB22D1103-SPE2DB23FE4ML
    Delivery Order

The Defense Logistics Agency awarded a $884 delivery order to Amerisourcebergen Drug Corporation for 140 mg/ml Repatha SureClick prefilled syringes. The firm fixed price order is for delivery to a location in Conshohocken, Pennsylvania between June 21-22, 2023. Repatha is an injectable PCSK9 inhibitor medication used to reduce low-density lipoprotein cholesterol. This order was placed under an existing DLA pharmaceuticals contract vehicle to supply Repatha to support the Department of Defense's treatment of cardiovascular conditions. No set aside designation or subcontractors were identified.

Generated 12/20/23, 2:42 PM